9-Hydroxyellipticine hydrochloride is used as an inhibitor of Topoisomerase II (TopoII) and Ryanodine Receptor (RyR); it exhibits antitumor, antioxidant, and catecholamine-releasing activities; it is applied in studies investigating selective inhibition of p53 protein phosphorylation in cancer cell lines such as Lewis lung carcinoma and SW480 (human colon cancer); it is also used in vivo to induce chromosomal clumping, sister chromatid exchange, chromatid aberrations, and micronucleus formation in murine bone marrow cells for genotoxicity and anticancer mechanism research.